CN1173714C - Chinese-medicinal capsule for preventing and treating cerebral apoplexy - Google Patents

Chinese-medicinal capsule for preventing and treating cerebral apoplexy Download PDF

Info

Publication number
CN1173714C
CN1173714C CNB001084569A CN00108456A CN1173714C CN 1173714 C CN1173714 C CN 1173714C CN B001084569 A CNB001084569 A CN B001084569A CN 00108456 A CN00108456 A CN 00108456A CN 1173714 C CN1173714 C CN 1173714C
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
cerebral apoplexy
medicine capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001084569A
Other languages
Chinese (zh)
Other versions
CN1276220A (en
Inventor
穆永森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001084569A priority Critical patent/CN1173714C/en
Publication of CN1276220A publication Critical patent/CN1276220A/en
Application granted granted Critical
Publication of CN1173714C publication Critical patent/CN1173714C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention relates to a traditional Chinese medicine capsule for treating cerebral apoplexy, which is prepared by mixing powdered preparations prepared from the following crude medicine according to parts by weight: 1 part of hemlock parsley, 1 to 10 parts of ground beetle, 3 to 20 parts of earthworm, 20 to 30 parts of red sage root and 10 to 20 parts of Japanese thistle. The traditional Chinese medicine capsule has the functions of supplementing Qi, restoring yang, dispelling stasis, dredging the vessels, expelling wind, dissipating phlegm, calming the liver, subsiding yang, restoring consciousness, inducing resuscitation, nourishing yin, activating blood circulation and softening the blood vessels. Clinical application shows that the traditional Chinese medicine capsule has special curative effects on hemiplegia, wry mouth and eyes, inhibited speech, vertigo, headache, numbness of the limbs, etc. With the advantages of strong medicinal effect, treatment of both the manifestation and the root cause of diseases, rapidness for taking effect, convenience for taking, no toxic or side effect and high clinical effective cure rate of 97.5%, the traditional Chinese medicine capsule is good medicine with special effects for treating and preventing cerebral apoplexy.

Description

A kind of Chinese medicinal capsule of preventing and treating apoplexy
The present invention relates to medical drugs technical field from the material of plant and animal.
Apoplexy (cerebral thrombosis, cerebral infarction) is a common ailment of middle-aged and old, and sickness rate increases with age, and crowd below 40 years old also has morbidity in recent years, and cumulative how on the rise.China's town and country apoplexy sickness rate is about 120-180/10 ten thousand, and domestic (cerebral thrombosis, cerebral infarction) sickness rate is about 14%, and national annual new cases number is about 1,300,000 people.Because China has entered aging society, estimates that sickness rate will constantly rise from now on.Sickness rate accounts for 2-3% in American-European countries, and the Asia sickness rate is higher, and India and Sri Lanka are higher than 27.2-32%.But still do not have at present this sick specific drug of treatment is arranged.
The Chinese medicinal capsule that the purpose of this invention is to provide a kind of anti-apoplexy, its drug effect is powerful, uses rapidly, and treating both the principal and secondary aspects of a disease has no side effect, effective percentage cure rate height, taking convenience.
The present invention is achieved in that a kind of Chinese medicinal capsule of preventing and treating apoplexy, it is characterized in that this medicine is each component of following portions by weight to be pulverized the back mixed preparing form: 1 part of Rhizoma Chuanxiong, and worm (claiming eupolyphaga again) 1-10 part, 2-8 part is preferable; Pheretima 3-20 part, 7-17 part is preferable; Radix Salviae Miltiorrhizae 20-30 part, 22-28 part is preferable; Radix Ilicis Pubescentis (claiming Artemisia anomala again) 10-20 part, 12-18 part is preferable.
Preparation of the present invention, every medicine can directly be pulverized direct preparation from pharmacy, also can adopt conventional Chinese medicine processing method to concoct in advance, pulverizes directly and mixes.Perhaps effective component extracting powder process mixes, and makes capsule and forms.The proportional quantity that guarantees each effective ingredient gets final product.
The traditional Chinese medical science thinks that apoplexy takes place, mainly be the internal organs deficiency of both QI and blood, at the situation eyeball of the heart, liver,kidney,spleen imbalance of YIN and YANG or recruit the sense exopathogen or be worried angry or drink gluttony or chamber do not save etc. and all can become paathogenic factor and bring out, the lighter's heresy is gone into meridians, and the meridians sign appears, weight person causes deficiency of kidney-YIN, and liver-yang rises suddenly and sharply, and gas is contrary with blood, hold fire under the arm and hold expectorant under the arm, the horizontal meridians of scurrying, the disturbance mind is hoodwinked key clearly.Since positive QI-insufficiency, collaterals being void and defenceless, interspaces of skin and muscles being loose, ailment said due to cold or exposure is taken advantage of a weak point, and the priming damp-phlegm is fled meridians, so diseases such as deviation of the mouth with numbness and paralysis, dysphonia, hemiplegia, numbness of the skin, numb hand and foot, limbs contracture occur.The blood vessel generation blood that doctor trained in Western medicine then emphasizes to supply cerebral tissue is fastened and is formed infraction, all will clinical symptoms occur because of the cerebral tissue hypoxic-ischemic.Blood is fastened or the infarction factor has: tunica intima is coarse.As atheroma or endovasculitis.Blood flow is slow, reduces cardiac insufficiency etc., cardiac insufficiency etc. as blood pressure.The change of blood component: as dehydration and blood concentrates, erythrocytosis etc. such as increase at blood viscous, coagulability.Intra-auricular clot or bacterial endocarditis are done the vegetation that comes off on the film during arrhythmia of auricular fibrillation or other character, so apoplexy (cerebral thrombosis, cerebral infarction) patient is many with heart disease and hypertension.The inventor through concentrating on studies, adopts above-mentioned formulated to form through the science screening according to theory of Chinese medical science.
Medicated powder of the present invention has supplementing QI to revive YANG, eliminating blood stasis and smoothing collaterals, the eliminating phlegm that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., suppressing the hyperactive liver and subsiding YANG, effect rapidly, treating both the principal and secondary aspects of a disease, effectively the cure rate height, have no side effect, characteristics such as taking convenience.
Following embodiments of the invention, but not as limitation of the invention.
Embodiment:
Rhizoma Chuanxiong, worm, Pheretima, Radix Salviae Miltiorrhizae, Radix Ilicis Pubescentis in the prescription are purchased from pharmacy and be ground into powder, directly be made into, perhaps adopt modern high technology biological extraction technology, refine extraction, mixing granulation, drying and crushing to incapsulate promptly after (90 days) through special processing processing.
Directly Pei Zhi each Chinese medicine medicated powder parts by weight proportioning is as follows:
Figure C0010845600051
Clinical certain provincial hospital clinical data: this organizes 83 routine patients, male's 64 examples wherein, and women's 19 examples, the age is at 39 years old-72 years old, and average 60.8 years old, acute stages 32 people, convalescent periods 28 people, sequela 23 people.All case all meets the characteristics of incidence of apoplexy (cerebral thrombosis, cerebral infarction) and has tangible sign.25 examples are through CT examination prompting low-density kitchen range, and all bright cerebral embolism that is diagnosed as of sequela person has been left over hemiplegia, symptoms such as language or function of deglutition obstacle behind acute stages treated.
Therapeutic Method: acute stage intracranial hypertension person can be equipped with the dehydrant treatment.Take medicine every day 4 times, each 5,20 is a course of treatment (getting final product rehabilitation general 1-2 course of treatment).
Criterion of therapeutical effect.The basic healing: clinical symptoms and sign complete obiteration.Produce effects: clinical sign disappears, and muscular strength improves more than the II level.Take a turn for the better: flesh is done and is improved more than the I level, and simultaneous phenomenon changes to some extent.Invalid: clinical symptoms and sign do not have change.
Symptom and therapeutic outcome: this group patient dysphonia 28 examples, cure 22 examples substantially, produce effects 6 examples.Hemiplegia 29 examples are cured 24 examples substantially, produce effects 4 examples, invalid 1 example.Dizziness headache 24 examples are cured 18 examples substantially, produce effects 6 examples.Deviation of the mouth with numbness and paralysis 19 examples are cured 19 examples substantially.Numb limbs and tense tendons 15 examples are cured 12 examples substantially, produce effects 3 examples.Obnubilation 6 examples, produce effects 4 examples, 1 example that takes a turn for the better, invalid 1 example.Auditory dysesthesia companion nausea and vomiting dysphagia 21 examples.Basic 17 examples, produce effects 7 examples, no change 2 examples of curing.As can be seen, this Chinese medicinal formulae all has positive effect to the various symptoms of apoplexy (cerebral thrombosis, cerebral infarction) from above symptom and curative effect.After the medication onset time generally at 2-8 days, not only to acute stage, convalescent period curative effect good good, also very obvious to cerebral thrombosis, cerebral infarction sequela curative effect.Clinical effective cure rate reaches 97.5%.This medical instrument is effective in cure significantly, and onset is quick, characteristics such as have no side effect, but informal dress prevention of brain apoplexy.Clinical verification: we are brief and concise, produce the meaning uniqueness, and medication is superior, and prescription is smooth, still are desirable side.Use this side, whenever obtain good effect.

Claims (3)

1, a kind of Chinese medicinal capsule of preventing and treating apoplexy is characterized in that this medicine is to mix after each component of following portions by weight is pulverized: 1 part of Rhizoma Chuanxiong, worm 1-10 part, Pheretima 3-20 part, Radix Salviae Miltiorrhizae 20-30 part, Radix Ilicis Pubescentis 10-20 part.
2, Chinese medicinal capsule according to claim 1 is characterized in that the parts by weight of each component being: 1 part of Rhizoma Chuanxiong, worm 2-8 part, Pheretima 7-17 part, Radix Salviae Miltiorrhizae 22-28 part, Radix Ilicis Pubescentis 12-18 part.
3, Chinese medicinal capsule according to claim 1 and 2 is characterized in that each component extracts active ingredients is granulated, drying, and after above-mentioned parts by weight preparation, pulverize gets final product.
CNB001084569A 2000-05-26 2000-05-26 Chinese-medicinal capsule for preventing and treating cerebral apoplexy Expired - Fee Related CN1173714C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001084569A CN1173714C (en) 2000-05-26 2000-05-26 Chinese-medicinal capsule for preventing and treating cerebral apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001084569A CN1173714C (en) 2000-05-26 2000-05-26 Chinese-medicinal capsule for preventing and treating cerebral apoplexy

Publications (2)

Publication Number Publication Date
CN1276220A CN1276220A (en) 2000-12-13
CN1173714C true CN1173714C (en) 2004-11-03

Family

ID=4579202

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001084569A Expired - Fee Related CN1173714C (en) 2000-05-26 2000-05-26 Chinese-medicinal capsule for preventing and treating cerebral apoplexy

Country Status (1)

Country Link
CN (1) CN1173714C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998179A (en) * 2016-07-01 2016-10-12 王欣 Medicinal liquor for preventing cerebral apoplexy

Also Published As

Publication number Publication date
CN1276220A (en) 2000-12-13

Similar Documents

Publication Publication Date Title
CN113456779A (en) Traditional Chinese medicine medicated wine for massaging and smearing, preparation method and application thereof
CN100394955C (en) Chinese traditional medicine preparation for treating bone fracture and traumatic injury
CN102895349A (en) Traditional Chinese medicine tea for treating hypertension, hyperlipidemia and hyperglycemia
CN108175795A (en) A kind of plaster
CN103550685B (en) A kind of Chinese medicine composition for the treatment of lumbago and skelalgia
CN101966298B (en) Traditional Chinese medicine for treating wind-cold numbness
CN106039245A (en) External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof
CN1840100A (en) Tendon-relaxing pain-relieving Chinese herbal powder
CN101940739A (en) Traditional Chinese medicine for treating gout
CN112603987B (en) Patch for treating male erectile dysfunction and preparation method thereof
CN1173714C (en) Chinese-medicinal capsule for preventing and treating cerebral apoplexy
CN105250970A (en) Traditional Chinese medicine combined treatment method of bone diseases
CN104056080A (en) Traditional Chinese medicine composition for treating cerebral thrombosis sequelae
CN114617939B (en) Traditional Chinese medicine preparation for treating ischemic cerebral apoplexy
CN104398712A (en) Chinese medicinal preparation for treating facial spasm and preparation method
CN104288604B (en) A kind of Chinese medicine composition for treating cerebral infarction
CN116492412B (en) Traditional Chinese medicine composition for treating peripheral neuritis with blood deficiency and collateral obstruction syndrome
CN101983712A (en) Novel medicament for treating coronary heart disease
CN101219202A (en) Soup for strengthening tendon and waist
CN106109965A (en) A kind of Chinese medicine composition treating flaccidity disease
CN105194411A (en) Formula of traditional Chinese medicine for treating scapulobumeral periarthritis
CN105362500A (en) Anti-aging traditional Chinese medicine preparation for medicated bath and preparation method of anti-aging traditional Chinese medicine preparation
CN105250856A (en) Chinese herb composition for treating climacteric syndrome
Qingsong et al. Research Progress in the Treatment of Diabetes Complications with Yiqi Huoxue Prescriptions Combined with Acupuncture and Moxibustion
CN104645244A (en) Traditional Chinese medicine composition for treating atherosclerosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee